The Times tested for lead, mercury and other heavy metals in Altadena and Pacific Palisades. From respiratory problems to ...

A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

A Bay Area woman fights back against the odds to raise awareness about lung cancer in Asian American women who have never smoked.

The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been ...

Research led by Professors Jianxing He and Wenhua Liang from the First Affiliated Hospital of Guangzhou Medical University ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today shared new preclinical data for IPH4502, its novel and differentiated topoisomerase I inhibitor Antibody Drug ...

In April 2025, the internationally renowned academic journal The Journal of the American Medical Association (JAMA) (Impact Factor: 63.5) published online a study titled “Non-Risk-Based Lung Cancer ...

Join us for a quick overview of BioNTech SE, a Biotechnology company whose shares moved 0.3% today. Here are some facts about ...

ImCheck Announces Oral Presentation of Updated ICT01 Efficacy Data in First-line AML at the ASCO Annual Meeting 2025 ...

New research shows that Medicaid expansion was linked to a 2.1% increase in timely lung cancer surgeries and a 2.8% rise in procedures at high-volume hospitals, highlighting how policy changes can ...

Cancer Statistics Explorer Network. Lambe G, Durand M, Buckley A, Nicholson S, Mcdermott R. Adenocarcinoma of the lung: from BAC to the future. Insights Imaging. 2020;11(1):69.